Royal DSM is a global purpose-led, science-based company in Nutrition, Health and Bioscience. DSM’s purpose is to create brighter lives for all. With its products and solutions DSM addresses some of the world’s biggest challenges whilst creating simultaneously economic, environmental and societal value for all its stakeholders; customers, employees, shareholders, and society-at-large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.
Royal DSM, a global purpose-led science-based company, confirmed its resolution to declare a dividend for the financial year 2021 of €2.50 per ordinary share was passed today, 10 May 2022, at its Annual General Meeting of Shareholders.
10 May 2022
Royal DSM, a global purpose-led science-based company, today held its Annual General Meeting of Shareholders. All the resolutions on the agenda were approved by the shareholders.
10 May 2022
Royal DSM, a global purpose-led science-based company, has repurchased 40,085 of its own shares in the period from 2 May 2022 up to and including 6 May 2022 at an average price of €156.08.
10 May 2022
Geraldine Matchett is Co-Chief Executive Officer, Chief Financial Officer and Member of the Managing Board. She was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2014. Her current term will end in 2022.
Dimitri de Vreeze is Co-Chief Executive Officer, Chief Operating Officer and Member of the Managing Board. He was appointed as Co-CEO on 15 February 2020 and joined DSM’s Managing Board in 2013. His current term will end in 2021.
DSM's Factbook provides investors and analysts with an introduction to the company and our key individual businesses.
